CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Updated report

Provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Ono and Gilead in ONO-4059 licensing pact

December 20, 2014 : big pharma, Gilead Sciences, partnering

Ono Pharmaceutical and Gilead Sciences have entered into an exclusive license agreement for the development and commercialization of ONO-4059 more »

Novo Nordisk and Xencor seeking biologic drug candidates using XmAb technologies

December 18, 2014 : big pharma, Novo Nordisk, partnering

Xencor has entered into a collaboration and licensing agreement with Novo Nordisk to jointly discover novel biologic drug candidates for an undisclosed target by combining multiple Xencor XmAb technologies more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Roche acquires Bina and Dutalys in festive shopping spree

December 20, 2014 : M&A, Roche

Roche has agreed to acquire Dutalys and Bino Technologies in a end of year acquisition push more »

Merck acquires OncoEthix, gains OTX015

December 18, 2014 : big pharma, M&A, Merck

Merck has acquired OncoEthix more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Juno Therapeutics lands bumper $265 million IPO

December 20, 2014 : financing, ipo

Juno Therapeutics announced the pricing of its initial public offering of 11,022,917 shares of common stock at a price to the public of $24.00 per share more »

Medovex seeks $80 million IPO

December 20, 2014 : financing, ipo

Medovex has priced its initial public offering of 1,391,305 units, each unit consisting of one share of common stock and one Series A Warrant, at a price to the public of $5.75 per unit more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Biotech rumor mill : Helix BioPharma in the spotlight

December 8, 2014 : big pharma, dealtalk, M&A

Biotech rumor mill: Helix BioPharma Corp. announced Friday that it has begun “a comprehensive exploration of growth opportunities,” code that most of the biotech market has taken to mean the company has a shopping list of potential acquisitions and will be buying snap-on targets soon. more »

Bayer hungry for pharma deals to expand business

October 31, 2014 : Bayer, big pharma, dealtalk, pharma deals

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals.  more »

 More dealtalk

CP Scorecard

NEW Top life science deals of 2014 revealed using our CP Scorecard tool.

Partnering | M&A | Financing |
Completed IPOs

Featured reports

Manufacturing & Supply Partnering Terms and Agreements

Publication date: December 2014

Cancer Vaccine Partnering Terms and Agreements

Publication date: December 2014

Asset Purchase Partnering Terms & Agreements

Publication date: December 2014

Royalty Financing Partnering Terms and Agreements

Publication date: December 2014

Cancer Diagnostics Partnering Terms and Agreements

Publication date: December 2014

Gene Therapy Partnering Terms and Agreements

Publication date: December 2014

Biomarker Partnering Terms and Agreements

Publication date: November 2014

Companion Diagnostics Partnering Terms and Agreements

Publication date: November 2014

Personalized Medicine Partnering Terms and Agreements

Publication date: November 2014

Pharmacogenomics Partnering Terms and Agreements

Publication date: November 2014

Option and Evaluation Partnering Terms and Agreements

Publication date: November 2014

View all reports

Print Friendly
cpbannerad300x150new3gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
biotech-china-300x150jpg
e57300x150animgif